Artificial Intelligence
Microsoft Teams Up With AstraZeneca on AI Incubator
(Bloomberg) — Microsoft is teaming up with drugmaker AstraZeneca on creating a health-tech incubator in Paris aimed at bringing new solutions to the field’s most difficult problems.
Startups joining the AI Factory for Health will gain access to AstraZeneca’s clinical expertise and legal skills, along with its links to health-care establishments and data, the companies said in a statement. Microsoft will provide technological skills and the services of its Azure cloud network.
Read: Microsoft Built a Bot to Match Patients to Clinical Trials
The collaboration builds on Microsoft’s AI Factory, which has already supported 27 startups in various fields. It also involves Inria, the French national research institute for the digital sciences, and venture capital investors Partech Partners and Serena, according to the statement.
Pharma companies are turning to AI, machine learning and advanced computing to speed the costly search for drugs and determine which approaches are most likely to yield successful products.
AstraZeneca just announced a collaboration with Schrodinger to use that company’s technology for predicting molecular binding, a key part of drug activity.
Read also:
https://www.businessliveme.com/economy/banking-finance/the-one-job-in-banking-robots-cant-take/
-
Uncategorized2 months ago
Oman Oil Marketing Company partners with Ihsaan Association to support its activities
-
Alamaliktistaad Magazines4 weeks ago
Al-iktisaad, October 24
-
OER Magazines4 weeks ago
Signature, October 24
-
Commodities2 months ago
Gold Rangebound as Investors Brace for Key US Economic Data
-
Banking & Finance2 months ago
Apple Pay Officially Launched in Oman
-
Oil & Gas2 months ago
OQEP Appoints United Securities as Liquidity Provider Ahead of Landmark MSX Listing
-
Lifestyle2 months ago
Royal Opera House Muscat Welcomes First Shows of its 2024/25 Season
-
Magazines3 weeks ago
OER, October 24
You must be logged in to post a comment Login